Chronotherapy with Low-dose Aspirin for Primary Prevention

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

3,200

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Type 2 Diabetes
Interventions
DRUG

aspirin

100 mg/day upon awakening for five years

DRUG

aspirin

100 mg/day at bedtime for five years

Trial Locations (19)

26680

CS A Estrada, A Estrada

27002

CS Fingoi, Lugo

27220

CS Friol, Friol

32005

Complexo Hospitalario Universitario de Ourense, Ourense

36141

CS Vilaboa, Vilaboa

36156

CS Lerez, Pontevedra

36200

CS Tomiño, Tomiño

Bioengineering & Chronobilogy Labs., University of Vigo, Vigo

36202

CS Calle Cuba, Vigo

36205

CS A Doblada, Vigo

36209

CS Coia, Vigo

36214

CS Sardoma, Vigo

36216

CS Teis, Vigo

36250

CS Valmiñor, Nigrán

36300

CS Baiona, Baiona

36340

CS Panxón, Nigrán

36600

CS San Roque, Vilagarcía de Arousa

36780

CS A Guarda, La Guardia

36930

CS Bueu, Bueu

All Listed Sponsors
lead

University of Vigo

OTHER